These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8824064)

  • 1. Toward establishing an empirical basis for the diagnosis of oppositional defiant disorder.
    Angold A; Costello EJ
    J Am Acad Child Adolesc Psychiatry; 1996 Sep; 35(9):1205-12. PubMed ID: 8824064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment.
    Canino G; Shrout PE; Rubio-Stipec M; Bird HR; Bravo M; Ramirez R; Chavez L; Alegria M; Bauermeister JJ; Hohmann A; Ribera J; Garcia P; Martinez-Taboas A
    Arch Gen Psychiatry; 2004 Jan; 61(1):85-93. PubMed ID: 14706947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining oppositional defiant disorder.
    Rowe R; Maughan B; Costello EJ; Angold A
    J Child Psychol Psychiatry; 2005 Dec; 46(12):1309-16. PubMed ID: 16313431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired but undiagnosed.
    Angold A; Costello EJ; Farmer EM; Burns BJ; Erkanli A
    J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):129-37. PubMed ID: 9951211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant treatment for children: a community perspective.
    Angold A; Erkanli A; Egger HL; Costello EJ
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):975-84; discussion 984-94. PubMed ID: 10939226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of DSM-III-R criteria for disruptive childhood behaviors: confirmatory factor models.
    Fergusson DM; Horwood LJ; Lynskey MT
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1145-55; discussion 155-7. PubMed ID: 7982865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.
    Lahey BB; Pelham WE; Chronis A; Massetti G; Kipp H; Ehrhardt A; Lee SS
    J Child Psychol Psychiatry; 2006 May; 47(5):472-9. PubMed ID: 16671930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability and validity of the Oppositional Defiant Behavior Inventory.
    Harada Y; Saitoh K; Iida J; Sakuma A; Iwasaka H; Imai J; Hirabayashi M; Yamada S; Hirabayashi S; Uchiyama T; Ohta S; Amano N
    Eur Child Adolesc Psychiatry; 2004 Jun; 13(3):185-90. PubMed ID: 15254847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD.
    Harpold T; Biederman J; Gignac M; Hammerness P; Surman C; Potter A; Mick E
    J Nerv Ment Dis; 2007 Jul; 195(7):601-5. PubMed ID: 17632251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication.
    Nock MK; Kazdin AE; Hiripi E; Kessler RC
    J Child Psychol Psychiatry; 2007 Jul; 48(7):703-13. PubMed ID: 17593151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds.
    Fergusson DM; Horwood LJ; Lynskey MT
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1127-34. PubMed ID: 8282656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSM-III-R and DSM-III criteria for conduct disorder in preadolescent girls: specific but insensitive.
    Zoccolillo M; Tremblay R; Vitaro F
    J Am Acad Child Adolesc Psychiatry; 1996 Apr; 35(4):461-70. PubMed ID: 8919708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and desistance of oppositional defiant disorder in a community sample of children with ADHD.
    August GJ; Realmuto GM; Joyce T; Hektner JM
    J Am Acad Child Adolesc Psychiatry; 1999 Oct; 38(10):1262-70. PubMed ID: 10517059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should sex-specific norms be used to assess attention-deficit/hyperactivity disorder or oppositional defiant disorder?
    Waschbusch DA; King S
    J Consult Clin Psychol; 2006 Feb; 74(1):179-85. PubMed ID: 16551155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.
    Zimmermann P; Brückl T; Nocon A; Pfister H; Lieb R; Wittchen HU; Holsboer F; Angst J
    Arch Gen Psychiatry; 2009 Dec; 66(12):1341-52. PubMed ID: 19996039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DSM-IV panic disorder field trial: panic attack frequency and functional disability.
    Fyer AJ; Katon W; Hollifield M; Rassnick H; Mannuzza S; Chapman T; Ballenger JC
    Anxiety; 1996; 2(4):157-66. PubMed ID: 9160617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.